APA (7th ed.) Citation

SA, R., CW, K., CJ, H., KS, H., JM, P., S, E., . . . CW, H. (2024). A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention. The Journal of infectious diseases, 230(3), 696. https://doi.org/10.1093/infdis/jiae211

Chicago Style (17th ed.) Citation

SA, Riddler, et al. "A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention." The Journal of Infectious Diseases 230, no. 3 (2024): 696. https://doi.org/10.1093/infdis/jiae211.

MLA (9th ed.) Citation

SA, Riddler, et al. "A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention." The Journal of Infectious Diseases, vol. 230, no. 3, 2024, p. 696, https://doi.org/10.1093/infdis/jiae211.